Guangdong Jiaying Pharmaceutical Co Ltd (002198.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE1000008P1

Price
3.19 CNY
Market cap
1.62 bn CNY
P/E (2025)
53.12
P/S (2025)
4.22
Dividend yield
0.00 %
Net margin
7.94 %
Return on equity (ROE)
4.25 %
Return on assets (ROA)
3.59 %

Guangdong Jiaying Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue376.17 m CNY383.75 m CNY
Gross profit224.25 m CNY230.02 m CNY
Operating income25.26 m CNY44.68 m CNY
EBIT25.13 m CNY38.14 m CNY
Net income20.61 m CNY30.48 m CNY
Diluted EPS – continuing operations0.04 CNY0.06 CNY

Full history since 2004, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Guangdong Jiaying Pharmaceutical Co Ltd

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat ailments, colds, orthopedics, rheumatism, gynecology, hepatobiliary diseases, tonics, and gastrointestinal disorders. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Xiaoyan Lidan Tablets, and Jinju Wuhua tea, etc., as well as double throat lozenges and tablets, heavy psychotherapy, Yuqiao detoxification granules, orange peel cough granules, bone-setting Qili tablets and capsules, anti-inflammatory and choleretic tablets, chrysanthemum five-flower tea granules, Zhuang Yao Jian Shen pills, Gujing Shenrong pills, Guifuli Zhongwan, and stomach pain tablets. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meizhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.